Cargando…
Efficacy of tocilizumab in treatment of COVID-19 pneumonia: A case–control study from a tertiary care hospital
BACKGROUND AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome virus, which has affected billions of people across the globe. The pathogenesis of respiratory inflammation involves elevated concentration of interleukin-6; he...
Autores principales: | Shastri, Minal, Raval, Darshankumar Manubhai, Bharmal, Ummayhany Fakhruddin, Rathod, Vaishnavi M, Desai, Bhavi, Shah, Priyansh V., Jain, Mohak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746268/ https://www.ncbi.nlm.nih.gov/pubmed/36629229 http://dx.doi.org/10.4103/lungindia.lungindia_349_22 |
Ejemplares similares
-
A Triad of Trichobezoar: Rapunzel Syndrome, Severe Malnutrition, and Cerebral Venous Thrombosis
por: Shastri, Minal, et al.
Publicado: (2023) -
Mucormycosis, Diabetes and COVID-19 Pneumonia: Unleashing the Facts
por: Shastri, Minal, et al.
Publicado: (2022) -
Emphysematous Cystitis: A Fatal Complication of Uncontrolled Type-2 Diabetes Mellitus
por: Raval, Darshankumar M, et al.
Publicado: (2022) -
Idiopathic Retroperitoneal Fibrosis Presented As Urinary Tract Obstruction
por: Raval, Darshankumar M, et al.
Publicado: (2022) -
A Rare Phenotype of Inherited Cerebellar Ataxia
por: Raval, Darshankumar M, et al.
Publicado: (2022)